Rotavirus disease and vaccination: Impact on genotype diversity

Future Microbiology

Volumn 4, Issue 10, 2009, Pages 1303-1316

  Matthijnssens, Jelle ^a   Bilcke, Joke ^b   Ciarlet, Max ^c   Martella, Vito ^d   Bányai, Krisztián ^e   Rahman, Mustafizur ^a,f   Zeller, Mark ^a   Beutels, Philippe ^b   Van Damme, Pierre ^b   Van Ranst, Marc ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF BARI   (Italy)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^f INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Burden of disease; Epidemiology; Genetic diversity; Rotavirus; Vaccines

Indexed keywords

GLYCOPROTEIN; ROTAVIRUS VACCINE;

CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG TOLERABILITY; EPIDEMIC; GASTROENTERITIS; GENOTYPE; HUMAN; INCIDENCE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SEROTYPE; VACCINATION; VIRUS CLASSIFICATION; VIRUS INFECTION;

ANIMALS; GENETIC VARIATION; GENOTYPE; HUMANS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

ANIMALIA; ROTAVIRUS;

EID: 74749096213     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.96     Document Type: Review

References (135)

1. Estes M, Kapikian A: Rotaviruses. In: Fields Virology. Knipe DM, Howley PM, Griffin DE et al. (Eds). Kluwer Health/Lippincott, Williams and Wilkins, PA, USA, 1917-1974 (2007).
2. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI: Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9, 565-572 (2003).
3. WHO: External review of burden of disease attributable to rotavirus. 30 November to 1 December 2005. WHO, Geneva, Switzerland (2005). ■■ Comprehensive review of the worldwide rotavirus burden of disease.
4. Heaton PM, Ciarlet M: Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond. Clin. Infect. Dis. 45, 1618-1624 (2007).
5. Ward RL, McNeal MM, Steele AD: Why does the world need another rotavirus vaccine? Ther. Clin. Risk Manag. 4, 49-63 (2008).
6. Vesikari T, Matson DO, Dennehy P et al.: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 354, 23-33 (2006).
7. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR et al.: Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 354, 11-22 (2006). ■■ The above two references were jointly awarded "Lancet paper of the year 2006", describing safety and efficacy of the monovalent and pentavalent rotavirus vaccines in the two largest vaccine trials ever conducted in infants.
8. Goveia MG, Nelson CB, Ciarlet M: RotaTeq®: progress towards developing world access. J. Infect. Dis. (2009) (In Press).
9. Ciarlet M, Estes M: Rotaviruses: basic biology, epidemiology and methodologies. In: Encyclopedia of Environmental Microbiology. Britton G (Ed.). John Wiley & Sons, NY, USA, 2573-2773 (2002).
10. Desselberger U, Iturriza-Gómara M, Gray JJ: Rotavirus epidemiology and surveillance. Novartis Found. Symp. 238, 125-147; discussion 147-152 (2001).
11. Iturriza-Gómara M, Isherwood B, Desselberger U, Gray J: Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J. Virol. 75, 3696-3705 (2001).
12. Watanabe M, Nakagomi T, Koshimura Y, Nakagomi O: Direct evidence for genome segment reassortment between concurrently-circulating human rotavirus strains. Arch. Virol. 146, 557-570 (2001).
13. Unicomb LE, Podder G, Gentsch JR et al.: Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J. Clin. Microbiol. 37, 1885-1891 (1999).
14. Desselberger U: Genome rearrangements of rotaviruses. Adv. Virus Res. 46, 69-95 (1996).
15. Iturriza-Gómara M, Kang G, Mammen A et al.: Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J. Clin. Microbiol. 42, 2541-2547 (2004).
16. Cunliffe NA, Bresee JS, Gentsch JR, Glass RI, Hart CA: The expanding diversity of rotaviruses. Lancet 359, 640-642 (2002).
17. Palombo EA: Genetic ana lysis of group A rotaviruses: evidence for interspecies transmission of rotavirus genes. Virus Genes 24, 11-20 (2002).
18. Matthijnssens J, Rahman M, Ciarlet M, Van Ranst M: Emerging human rotavirus genotypes. In: Viruses in the Environment. Palombo EA, Kirkwood CD (Eds). Research Signpost, Trivandrum, India. 171-219 (2008). ■■ Very comprehensive review on the emergence and spread of unusual human rotavirus G genotypes.
19. Martella V, Bányai K, Matthijnssens J, Buonavoglia C, Ciarlet M: Zoonotic aspects of rotaviruses. Vet. Microbiol. (2009) (Epub ahead of print). ■ Describes the impact of animal rotaviruses on the evolution of human rotaviruses.
20. Bilcke J, Van Damme P, Van Ranst M, Hens N, Aerts M, Beutels P: Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-ana lysis. PLoS One 4, e6060 (2009). ■■ Very comprehensive systematic review with meta-ana lysis of prospective studies estimating the incidence of symptomatic rotavirus by level of development.
21. de Zoysa I, Feachem RG: Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull. World Health Organ. 63, 569-583 (1985). ■ Study indicating that improvements in water supply, sanitation or hygiene may not decrease rotavirus incidence, as available incidence rates were similar between developed and developing countries.
22. Bilcke J, Beutels P: Reviewing the cost-effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources. Pharmacoeconomics 27(4), 281-297 (2009).
23. Mrukowicz J, Szajewska H, Vesikari T: Options for the prevention of rotavirus disease other than vaccination. J. Pediatr. Gastroenterol. Nutr. 46(Suppl. 2), S32-S37 (2008).
24. Cook SM, Glass RI, LeBaron CW, Ho MS: Global seasonality of rotavirus infections. Bull. World Health Organ. 68, 171-177 (1990).
25. Intusoma U, Sornsrivichai V, Jiraphongsa C, Varavithaya W: Epidemiology, clinical presentations and burden of rotavirus diarrhea in children under five seen at Ramathibodi Hospital, Thailand. J. Med. Assoc. Thai. 91, 1350-1355 (2008).
26. Mertens PPC, Duncan R, Attoui H, Dermody TS: Reoviridae. In: Virus Taxonomy: Eight Report of the International Committee on Taxonomy of Viruses. Fauquet C, Mayo MA, Maniloff J, Desselberger U, Ball LA (Eds). Elsevier, Academic Press, Amsterdam, Holland, 447-560 (2005).
27. Greenberg H, McAuliffe V, Valdesuso J et al.: Serological ana lysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect. Immun. 39, 91-99 (1983).
28. Iturriza-Gómara M, Wong C, Blome S, Desselberger U, Gray J: Rotavirus subgroup characterisation by restriction endonuclease digestion of a cDNA fragment of the VP6 gene. J. Virol. Methods 105, 99-103 (2002).
29. Iturriza-Gómara M, Wong C, Blome S, Desselberger U, Gray J: Molecular characterization of VP6 genes of human rotavirus isolates: correlation of genogroups with subgroups and evidence of independent segregation. J. Virol. 76, 6596-6601 (2002).
30. Gorziglia M, Larralde G, Kapikian AZ, Chanock RM: Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc. Natl Acad. Sci. USA 87, 7155-7159 (1990).
31. Schumann T, Hotzel H, Otto P, Johne R: Evidence of interspecies transmission and reassortment among avian group A rotaviruses. Virology 386(2), 334-343 (2009).
32. Trojnar E, Otto P, Johne R: The first complete genome sequence of a chicken group A rotavirus indicates independent evolution of mammalian and avian strains. Virology 386(2), 325-333 (2009).
33. Collins PJ, Martella V, Buonavoglia C, O'Shea H: Identification of a G2-like porcine rotavirus bearing a novel VP4 type, P[32]. (2009) (Submitted manuscript).
34. Solberg OD, Hasing ME, Trueba G, Eisenberg JN: Characterization of novel VP7, VP4, and VP6 genotypes of a previously untypeable group A rotavirus. Virology 385, 58-67 (2009).
35. Matthijnssens J, Ciarlet M, Heiman E et al.: Full genome-based classification of rotaviruses reveals a common origin between human Wa-like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J. Virol. 82, 3204-3219 (2008). ■■ Paper describing a novel rotavirus classification system approved and adopted by most rotavirus research groups.
36. Ciarlet M, Liprandi F, Conner ME, Estes MK: Species specificity and interspecies relatedness of NSP4 genetic groups by comparative NSP4 sequence analyses of animal rotaviruses. Arch. Virol. 145, 371-383 (2000).
37. Cunliffe NA, Woods PA, Leite JP et al.: Sequence ana lysis of NSP4 gene of human rotavirus allows classification into two main genetic groups. J. Med. Virol. 53, 41-50 (1997).
38. Horie Y, Masamune O, Nakagomi O: Three major alleles of rotavirus NSP4 proteins identified by sequence ana lysis. J. Gen. Virol. 78, 2341-2346 (1997).
39. Kirkwood CD, Palombo EA: Genetic characterization of the rotavirus nonstructural protein, NSP4. Virology 236, 258-265 (1997).
40. Mori Y, Borgan MA, Ito N, Sugiyama M, Minamoto N: Sequential ana lysis of nonstructural protein NSP4s derived from group A avian rotaviruses. Virus Res. 89, 145-151 (2002).
41. Matthijnssens J, Ciarlet M, Rahman M et al.: Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch. Virol. 153, 1621-1629 (2008).
42. Maes P, Matthijnssens J, Rahman M, Van Ranst M: RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol. 9, 238 (2009).
43. Matthijnssens J, Potgieter CA, Ciarlet M et al.: Are human P[14] rotavirus strains the result of interspecies transmissions from sheep or other ungulates belonging to the mammalian order of Artiodactyla? J. Virol. 83, 2917-2929 (2009). ■ Paper describing the identification of unusual P[14]-carrying rotavirus isolated from humans and animals, and showing a largely conserved genome constellation.
44. Van Damme P, Giaquinto C, Maxwell M, Todd P, Van der Wielen M: Distribution of rotavirus genotypes in Europe, 2004-2005: the REVEAL Study. J. Infect. Dis. 195(Suppl. 1), S17-S25 (2007).
45. Rendi-Wagner P, Kundi M, Mikolasek A et al.: Active hospital-based surveillance of rotavirus diarrhea in Austrian children, period 1997 to 2003. Wien Klin. Wochenschr. 118, 280-285 (2006).
46. Orenstein EW, Fang ZY, Xu J et al.: The epidemiology and burden of rotavirus in China: a review of the literature from 1983 to 2005. Vaccine 25, 406-413 (2007).
47. Brandt CD, Kim HW, Rodriguez WJ et al.: Pediatric viral gastroenteritis during eight years of study. J. Clin. Microbiol. 18, 71-78 (1983).
48. Haffejee IE: The epidemiology of rotavirus infections: a global perspective. J. Pediatr. Gastroenterol. Nutr. 20, 275-286 (1995).
49. Rahman M, Sultana R, Ahmed G et al.: Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg. Infect. Dis. 13, 18-24 (2007).
50. Santos N, Hoshino Y: Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 15, 29-56 (2005).
51. Beards GM, Desselberger U, Flewett TH: Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988. J. Clin. Microbiol. 27, 2827-2833 (1989).
52. Stupka JA, Carvalho P, Amarilla AA, Massana M, Parra GI: National rotavirus surveillance in Argentina: high incidence of G9P[8] strains and detection of G4P[6] strains with porcine characteristics. Infect. Genet. Evol. (2009) (Epub ahead of print).
53. Endara P, Trueba G, Solberg OD et al.: Symptomatic and subclinical infection with rotavirus P[8]G9, rural Ecuador. Emerg. Infect. Dis. 13, 574-580 (2007).
54. Sanchez-Fauquier A, Montero V, Moreno S et al.: Human rotavirus G9 and G3 as major cause of diarrhea in hospitalized children, Spain. Emerg. Infect. Dis. 12, 1536-1541 (2006).
55. De Grazia S, Ramirez S, Giammanco GM et al.: Diversity of human rotaviruses detected in Sicily, Italy, over a 5-year period (2001-2005). Arch. Virol. 152, 833-837 (2007).
56. Lin YP, Chang SY, Kao CL et al.: Molecular epidemiology of G9 rotaviruses in Taiwan between 2000 and 2002. J. Clin. Microbiol. 44, 3686-3694 (2006).
57. Santos N, Volotao EM, Soares CC, Campos GS, Sardi SI, Hoshino Y: Predominance of rotavirus genotype G9 during the 1999, 2000, and 2002 seasons among hospitalized children in the city of Salvador, Bahia, Brazil: implications for future vaccine strategies. J. Clin. Microbiol. 43, 4064-4069 (2005). ■ One of many examples of the emergence of rotavirus genotype G9 in the human population before introduction of any rotavirus vaccine.
58. Rahman M, Matthijnssens J, Goegebuer T et al.: Predominance of rotavirus G9 genotype in children hospitalized for rotavirus gastroenteritis in Belgium during 1999-2003. J. Clin. Virol. 33, 1-6 (2005).
59. Rodrigues F, Iturriza M, Gray J, Januario L, Lemos L: Epidemiology of rotavirus in Portugal: G9 as a major cause of diarrhoea in non-hospitalised children. J. Clin. Virol. 40, 214-217 (2007).
60. Khamrin P, Peerakome S, Wongsawasdi L et al.: Emergence of human G9 rotavirus with an exceptionally high frequency in children admitted to hospital with diarrhea in Chiang Mai, Thailand. J. Med. Virol. 78, 273-280 (2006).
61. Cunliffe NA, Ngwira BM, Dove W et al.: Serotype G12 rotaviruses, Lilongwe, Malawi. Emerg. Infect. Dis. 15, 87-90 (2009).
62. de Rougemont A, Kaplon J, Lebon P et al.: Unexpected substitution of dominant rotavirus G genotypes in French hospitalized children over five consecutive seasons. Eur. J. Clin. Microbiol. Infect. Dis. 28(4), 403-407 (2008).
63. Kheyami AM, Nakagomi T, Nakagomi O, Dove W, Hart CA, Cunliffe NA: Molecular epidemiology of rotavirus diarrhea among children in Saudi Arabia: first detection of G9 and G12 strains. J. Clin. Microbiol. 46, 1185-1191 (2008).
64. Rahman M, Matthijnssens J, Yang X et al.: Evolutionary history and global spread of the emerging G12 human rotaviruses. J. Virol. 81, 2382-2390 (2007). ■ Paper describing high frequency of reassortments between unusual human G12 rotavirus strains and co-circulating human strains.
65. Uchida R, Pandey BD, Sherchand JB et al.: Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J. Clin. Microbiol. 44, 3499-3505 (2006).
66. Samajdar S, Varghese V, Barman P et al.: Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India. J. Clin. Virol. 36, 183-188 (2006).
67. Rahman M, Matthijnssens J, Nahar S et al.: Characterization of a novel P[25], G11 human group a rotavirus. J. Clin. Microbiol. 43, 3208-3212 (2005).
68. Banerjee I, Iturriza-Gómara M, Rajendran P et al.: Molecular characterization of G11P[25] and G3P[3] human rotavirus strains associated with asymptomatic infection in South India. J. Med. Virol. 79, 1768-1774 (2007).
69. Araujo IT, Assis RM, Fialho AM, Mascarenhas JD, Heinemann MB, Leite JP: Brazilian P[8], G1, P[8], G5, P[8], G9, and P[4], G2 rotavirus strains: nucleotide sequence and phylogenetic analysis. J. Med. Virol. 79, 995-1001 (2007).
70. Gouvea V, de Castro L, Timenetsky MC, Greenberg H, Santos N: Rotavirus serotype G5 associated with diarrhea in Brazilian children. J. Clin. Microbiol. 32, 1408-1409 (1994).
71. Alfieri AA, Leite JP, Nakagomi O et al.: Characterization of human rotavirus genotype P[8]G5 from Brazil by probehybridization and sequence. Arch. Virol. 141, 2353-2364 (1996).
72. Banerjee I, Ramani S, Primrose B et al.: Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J. Clin. Microbiol. 44, 2468-2474 (2006).
73. Adah MI, Wade A, Taniguchi K: Molecular epidemiology of rotaviruses in Nigeria: detection of unusual strains with G2P[6] and G8P[1] specificities. J. Clin. Microbiol. 39, 3969-3975 (2001).
74. Fischer TK, Steinsland H, Molbak K et al.: Genotype profiles of rotavirus strains from children in a suburban community in Guinea-Bissau, Western Africa. J. Clin. Microbiol. 38, 264-267 (2000).
75. Fischer TK, Page NA, Griffin DD et al.: Characterization of incompletely typed rotavirus strains from Guinea-Bissau: identification of G8 and G9 types and a high frequency of mixed infections. Virology 311, 125-133 (2003).
76. Banyai K, Martella V, Molnar P, Mihaly I, Van Ranst M, Matthijnssens J: Genetic heterogeneity in human G6P[14] rotavirus strains detected in Hungary suggests independent zoonotic origin. J. Infect. 59(3), 213-215 (2009).
77. Bányai K, Gentsch JR, Schipp R et al.: Dominating prevalence of P[8], G1 and P[8], G9 rotavirus strains among children admitted to hospital between 2000 and 2003 in Budapest, Hungary. J. Med. Virol. 76, 414-423 (2005).
78. Bányai K, Gentsch JR, Glass RI, Uj M, Mihaly I, Szucs G: Eight-year survey of human rotavirus strains demonstrates circulation of unusual G and P types in Hungary. J. Clin. Microbiol. 42, 393-397 (2004).
79. Bányai K, Gentsch JR, Griffin DD, Holmes JL, Glass RI, Szucs G: Genetic variability among serotype G6 human rotaviruses: identification of a novel lineage isolated in Hungary. J. Med. Virol. 71, 124-134 (2003).
80. Bányai K, Gentsch JR, Glass RI, Szucs G: Detection of human rotavirus serotype G6 in Hungary. Epidemiol. Infect. 130, 107-112 (2003).
81. Bányai K, Bogdan A, Domonkos G et al.: Genetic diversity and zoonotic potential of human rotavirus strains, 2003-2006, Hungary. J. Med. Virol. 81, 362-370 (2009).
82. Arista S, Vizzi E, Alaimo C, Palermo D, Cascio A: Identification of human rotavirus strains with the P[14] genotype by PCR. J. Clin. Microbiol. 37, 2706-2708 (1999).
83. Gerna G, Sarasini A, Parea M et al.: Isolation and characterization of two distinct human rotavirus strains with G6 specificity. J. Clin. Microbiol. 30, 9-16 (1992).
84. Cooney MA, Gorrell RJ, Palombo EA: Characterisation and phylogenetic ana lysis of the VP7 proteins of serotype G6 and G8 human rotaviruses. J. Med. Microbiol. 50, 462-467 (2001).
85. Diwakarla S, Clark R, Palombo EA: Expanding distribution of human serotype G6 rotaviruses in Australia. Microbiol. Immunol. 46, 499-502 (2002).
86. Palombo EA, Bishop RF: Genetic and antigenic characterization of a serotype G6 human rotavirus isolated in Melbourne, Australia. J. Med. Virol. 47, 348-354 (1995).
87. Matthijnssens J, Rahman M, Van Ranst M: Two out of the 11 genes of an unusual human G6P[6] rotavirus isolate are of bovine origin. J. Gen. Virol. 89, 2630-2635 (2008).
88. McDonald SM, Matthijnssens J, McAllen JK et al.: Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PLoS Pathog. 5(10), e1000634 (2009). ■ Paper describing G3P[8] sublineage genotype fluctuations in the first large-scale complete genome sequencing project for rotaviruses.
89. Arista S, Giammanco GM, De Grazia S et al.: Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population. J. Virol. 80, 10724-10733 (2006).
90. Martella V, Bányai K, Ciarlet M et al.: Relationships among porcine and human P[6] rotaviruses: evidence that the different human P[6] lineages have originated from multiple interspecies transmission events. Virology 344, 509-519 (2006).
91. Martella V, Colombrita D, Lorusso E et al.: Detection of a porcine-like rotavirus in a child with enteritis in Italy. J. Clin. Microbiol. 46, 3501-3507 (2008).
92. Ciarlet M, Hidalgo M, Liprandi F: Cross-reactive, serotype- and monotype-specific neutralization epitopes on VP7 of serotype G3 and G5 porcine rotavirus strains. Arch. Virol. 141, 601-614 (1996).
93. Ciarlet M, Pina CI, Garcia O, Liprandi F: Identification of bovine rotaviruses in Venezuela: antigenic and molecular characterization of a bovine rotavirus strain. Res. Virol. 148, 289-297 (1997).
94. Tsugawa T, Hoshino Y: Whole genome sequence and phylogenetic analyses reveal human rotavirus G3P[3] strains Ro1845 and HCR3A are examples of direct virion transmission of canine/feline rotaviruses to humans. Virology 230, 344-353 (2008).
95. Ciarlet M, Reggeti F, Pina CI, Liprandi F: Equine rotaviruses with G14 serotype specificity circulate among venezuelan horses. J. Clin. Microbiol. 32, 2609-2612 (1994).
96. Iša P, Wood AR, Netherwood T, Ciarlet M, Imagawa H, Snodgrass DR: Survey of equine rotaviruses shows conservation of one P genotype in background of two G genotypes. Arch. Virol. 141, 1601-1612 (1996).
97. Matthijnssens J, Rahman M, Martella V et al.: Full genomic ana lysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission. J. Virol. 80, 3801-3810 (2006).
98. Ciarlet M, Estes MK, Conner ME: Comparative amino acid sequence ana lysis of the outer capsid protein VP4 from four lapine rotavirus strains reveals identity with genotype P[14] human rotaviruses. Arch. Virol. 142, 1059-1069 (1997).
99. Martella V, Ciarlet M, Lavazza A et al.: Lapine rotaviruses of the genotype P[22] are widespread in Italian rabbitries. Vet. Microbiol. 111, 117-124 (2005).
100. Steyer A, Poljsak-Prijatelj M, Barlic-Maganja D, Marin J: Human, porcine and bovine rotaviruses in Slovenia: evidence of interspecies transmission and genome reassortment. J. Gen. Virol. 89, 1690-1698 (2008).
101. Matthijnssens J, Rahman M, Yang X et al.: G8 rotavirus strains isolated in the Democratic Republic of Congo belong to the DS-1-like genogroup. J. Clin. Microbiol. 44, 1801-1809 (2006).
102. Maunula L, Von Bonsdorff CH: Frequent reassortments may explain the genetic heterogeneity of rotaviruses: ana lysis of Finnish rotavirus strains. J. Virol. 76, 11793-11800 (2002).
103. Delayed onset and diminished magnitude of rotavirus activity - United States, November 2007-May 2008. MMWR Morb. Mortal. Wkly Rep. 57, 697-700 (2008).
104. Mast TC, Wang F, Goli V, Loughlin J, Bulotsky M, Seeger J: Post-licensure effectiveness of RotaTeq™ in preventing gastroenteritis. Presented at: 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Infectious Diseases Society of America (IDSA). Washington, DC, USA, 25-28 October 2008, 356 (Abstract G1-433). ■■ Communication reporting the very high effectiveness of the pentavalent rotavirus after 2 years of mass introduction in the USA.
105. Boom J, Tate J, Sahni L et al.: Presented at: 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Infectious Diseases Society of America (IDSA). Washington, DC, USA, 25-28 October 2008, 306 (Abstract G2-264).
106. Clark HF, Lawley D, Mallette LA, Dinubile MJ, Hodinka RL: Decline in cases of rotavirus gastroenteritis presenting to the children's hospital of Philadelphia after introduction of pentavalent rotavirus vaccine. Clin. Vaccine Immunol. 16, 382-386 (2009).
107. Daskalaki I, Wood S, Inumerable Y, Long S: Epidemiology of rotavirus-associated hospitalizations pre- and post-implementation of immunization: north Philadelphia, 2000-2008. Presented at: 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Infectious Diseases Society of America (IDSA). Washington, DC, USA, 25-28 October 2008, 356 (Abstract G1-432).
108. Patel J, Loeffelholz M: Reduction of severe rotavirus gastroenteritis following routine use of luve, oral, pentavalent rotavirus vaccine. Presented at: 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Infectious Diseases Society of America (IDSA). Washington, DC, USA, 25-28 October 2008, 356 (Abstract G1-433).
109. Harrison C, Jackson M, Olson-Burgess C, Selvarangan R: Fewer 2008 hospitalizations for rotavirus (RV) in Kansas City, two years post RV vaccine. Presented at: 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Infectious Diseases Society of America (IDSA). Washington, DC, USA, 25-28 October 2008, 356-357 (Abstract G1-435).
110. Hatch S, Fontecchio S, Gibson L, Ellison R: Rapid decline in pediatric rotavirus cases following introduction of rotavirus vaccine. Presented at: 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Infectious Diseases Society of America (IDSA). Washington, DC, USA, 25-28 October 2008, 357 (Abstract G1-436).
111. van der Donck I, van Hoovels L, de Leener K et al.: [Severe diarrhea due to rotavirus infection in a Belgian hospital 1981-2002]. Acta Clin. Belg. 58, 12-18 (2003).
112. Zeller M, Matthijnssens J, Rahman M, Van Ranst M: Possible immune evasion by G1 lineage I after vaccine introduction in Belgium? Presented at: 3rd European Rotavirus Biology Meeting. Loch Lomond, Scotland, 13-16 September 2009.
113. Nieto Guevara J, Lopez O, Gonzalez G: [Impact of rotavirus vaccine introduction on hospital admissions for severe acute gastroenteritis at the Children's Hospital in Panama City]. Rev. Panam. Salud Publica 24, 189-194 (2008).
114. Leite JP, Carvalho-Costa FA, Linhares AC: Group A rotavirus genotypes and the ongoing Brazilian experience: a review. Mem. Inst. Oswaldo Cruz 103, 745-753 (2008).
115. Amarilla A, Espinola EE, Galeano ME, Farina N, Russomando G, Parra GI: Rotavirus infection in the Paraguayan population from 2004 to 2005: high incidence of rotavirus strains with short electropherotype in children and adults. Med. Sci. Monit. 13, CR333-7 (2007).
116. Ferrera A, Quan D, Espinoza F: Increased prevalence of genotype G2P[4] among children with rotavirus -associated gastroenteritis in Honduras. Presented at: The 17th European Congress of Clinical Microbiology and Infectious Diseases ICC. Munich, Germany, 31 March-3 April 2007.
117. Patel MM, de Oliveira LH, Bispo AM, Gentsch J, Parashar UD: Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg. Infect. Dis. 14, 863-865 (2008).
118. O'Ryan M: The ever-changing landscape of rotavirus serotypes. Pediatr. Infect. Dis. J. 28, S60-S62 (2009).
119. Kirkwood C, Bogdanovic-Sakran N, Bishop R, Barnes G: Report of the Australian Rotavirus Surveillance Program 2003-2004. Commun. Dis. Intell. 28, 481-485 (2004).
120. Kirkwood C, Bogdanovic-Sakran N, Clark R, Masendycz P, Bishop R, Barnes G: Report of the Australian Rotavirus Surveillance Program, 2001/2002. Commun. Dis. Intell. 26, 537-540 (2002).
121. Kirkwood CD, Bogdanovic-Sakran N, Cannan D, Bishop RF, Barnes GL: National Rotavirus Surveillance Program annual report, 2004-2005. Commun. Dis. Intell. 30, 133-136 (2006).
122. Kirkwood CD, Bogdanovic-Sakran N, Clark R, Bishop RF, Barnes GL: Report of the Australian rotavirus surveillance program 2002-2003. Commun. Dis. Intell. 27, 492-495 (2003).
123. Kirkwood CD, Cannan D, Bogdanovic-Sakran N, Bishop RF, Barnes GL: National Rotavirus Surveillance Program annual report, 2005-2006. Commun. Dis. Intell. 30, 434-438 (2006).
124. Kirkwood CD, Cannan D, Bogdanovic-Sakran N, Bishop RF, Barnes GL: Australian Rotavirus Surveillance Program: annual report, 2006-2007. Commun. Dis. Intell. 31, 375-379 (2007).
125. Masendycz P, Bogdanovic-Sakran N, Kirkwood C, Bishop R, Barnes G: Report of the Australian Rotavirus Surveillance Program, 2000/2001. Commun. Dis. Intell. 25, 143-146 (2001).
126. Masendycz P, Bogdanovic-Sakran N, Palombo E, Bishop R, Barnes G: Annual report of the Rotavirus Surveillance Programme, 1999/2000. Commun. Dis. Intell. 24, 195-198 (2000).
127. Kirkwood CD, Cannan D, Boniface K, Bishop RF, Barnes GL: Australian Rotavirus Surveillance Program annual report, 2007/08. Commun. Dis. Intell. 32 (2009).
128. Vizzi E, Calvino E, Gonzalez R et al.: Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection. Clin. Diagn. Lab. Immunol. 12, 1157-1163 (2005).
129. Bertolotti-Ciarlet A, Ciarlet M, Crawford SE, Conner ME, Estes MK: Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 21, 3885-3900 (2003).
130. Johansen K, Hinkula J, Espinoza F et al.: Humoral and cell-mediated immune responses in humans to the NSP4 enterotoxin of rotavirus. J. Med. Virol. 59, 369-377 (1999).
131. Kirkwood CD, Boniface K, Richardson S, Taraporewala ZF, Patton JT, Bishop RF: Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children. J. Med. Virol. 80, 1090-1098 (2008).
132. Yang XL, Matthijnssens J, Sun H et al.: Temporal changes of rotavirus strain distribution in a city in the northwest of China, 1996-2005. Int. J. Infect. Dis. 12, 11-17 (2008).
133. Tcheremenskaia O, Marucci G, De Petris S et al.: Molecular epidemiology of rotavirus in central and southeastern Europe. J. Clin. Microbiol. 45, 2197-2204 (2007).
134. Strategic Advisory Group of Experts (SAGE); WHO: Weekly Epidemiological Record 84, 220-236 (2009). www.who.int/wer/2009/wer8423.pdf
135. RotaC. http://rotac.regatools.be